PDCD1 and infantile convulsions and choreoathetosis: In conclusion, this is the first case describing the clinical benefit of PD-1 inhibitor-involved maintenance therapy without progression in patients with advanced iCCA, demonstrating a potential treatment strategy of the PD-1 inhibitor plus capecitabine.